Field Notes for Investors.
Patient research. Enduring Value.
Independent ideas for investors who think beyond the next quarter.
Independent. Rigorous. Long-Term.
STOCK RESEARCH
From weekly commentary and monthly newsletters to in-depth insights and timely action alerts, we help long-term investors gain the clarity and conviction needed to navigate the markets with confidence.
Weekly
Goal Prices
Weekly updates to our Goal Price list keep you current with changing fundamentals, market conditions, and new information, helping you make more informed decisions.
Mondays
Market Observations
Each week, we write about market conditions, economic indicators and important individual stock developments to help investors understand what they may mean for their investments.
Monthly
Newsletter
Each month, we look beyond the headlines to review market developments, explore important themes, share portfolio ideas and examine individual stocks.
"The stock market is a device for transferring money from the impatient to the patient."
September 21, 2026
Market Observations for September 21, 2026
With the Dow Jones Industrial Average falling nearly 900 points (1.65% on a total return basis) and the Bloomberg 3000 Value index retreating 1.46% last week, we were reminded that […] Continue Reading...
September 14, 2026
Market Observations for September 14, 2026
It is hard to believe that 25 years have passed since your Editor turned down Fifth Avenue from 17th Street in Manhattan on what had been a beautiful Tuesday morning […] Continue Reading...
September 7, 2026
Market Observations for September 7, 2026
It has only been a week and Jeff Sommer, the usually pessimistic New York Times Sunday Columnist took Labor Day Weekend off, so we won’t know if his August 30th […] Continue Reading...
SERVING DIY INVESTORS
We are different.
We have decades of experience taking a disciplined, long-term approach to investing, combining our own rigorous research with practical insights designed to help individual investors act with clarity and conviction.
Who We Are
We are an independent investment publication focused on decision-useful research, fundamental number-crunching and qualitative analysis in the pursuit of unearthing undervalued stocks.
Who We Serve
We serve individual and institutional investors who think in years and value independent judgment, helping them make informed decisions without being distracted by market noise.
Differentiation
We distinguish ourselves through a disciplined Value-investing framework, rigorous fundamental research and a willingness to maintain our long-term view when market headwinds blow.
From the Editor
"We are not in the business of predicting the market. We are in the business of finding stocks worth owning and holding them for the fullness of time."
John Buckingham
Editor - A Patient Prospector
INSIGHTS & SPECIAL REPORTS
Deep dives with conviction.
We write in-depth market insights and special reports for investors seeking thoughtful perspectives and actionable ideas for their portfolios. Our research helps readers identify opportunities across the market while maintaining a steady, long-term perspective.
September 23, 2026
All About Our Monthly Newsletter
This is our signature publication, offering a monthly perspective on the markets beyond the day-to-day noise. Each issue features an Editor’s Note from Editor-in-Chief John Buckingham, along with a complete […] Continue Reading...
September 23, 2026
Start Here – A Patient Prospector
Welcome to A Patient Prospector! I’m John Buckingham, Editor-in-Chief and co-founding Executive Director at wealth management firm Value87 Investment Partners. At A Patient Prospector, we believe successful investing rarely comes […] Continue Reading...
September 22, 2026
All About Our Weekly Market Observations
There is never a shortage of market news. We might think there’s too much. Every week brings another deluge of economic reports, earnings announcements, interest-rate debates, geopolitical developments and other […] Continue Reading...
Research Access
Depth of research, matched to your commitment.
Whether you’re exploring our work or ready to make it part of your investing process, choose the level of access that fits your interests and commitment. Every plan offers independent research built in support of individual investors.
Level I
Free
Surface-level research access. The commentary, delivered weekly.
$0 / Month
- Weekly Market Observations (excludes individual stock analysis)
- Monthly Newsletter Editor's Note
- Special Report & Insight Previews
- Webinars
Level II
Premium
The complete analytical record. Rigorous research, without the noise.
$8 / Month
- Weekly Market Observations + Individual Stock Analysis
- Monthly Newsletter Editor's Note
- Special Report & Insight Previews
- Webinars
Level III
All Access
Portfolio-grade intelligence. The complete research experience.
$39 / Month
- Weekly Goal Price List
- Weekly Market Observations + Individual Stock Analysis
- Buy & Sell Action Alerts
- Monthly Newsletter
- Special Reports
- Investment Insights
- Premium Webinars
Save With Annual Billing!
Subscription fees shown above apply only to A Patient Prospector research and publication services. Investment advisory services are offered through MPS, an SEC-registered investment adviser, pursuant to a separate advisory agreement and are subject to advisory fees separate from any applicable A Patient Prospector subscription fees.
The Editor-in-Chief
John Buckingham
- Editor - A Patient Prospector
- Co-Founder - Value87 Investment Partners
For nearly 40 years, John Buckingham has applied the value-investing discipline inspired by Al Frank, Benjamin Graham and Warren Buffett. His investment experience spans countless market cycles and reflects the patience required to remain invested through them all.
He previously served as Chief Investment Officer of AFAM Capital and as Editor of The Prudent Speculator. John co-founded A Patient Prospector as an independent research platform, allowing him to focus on long-term investing without constraints.
His philosophy is deceptively simple: buy quality businesses at reasonable prices and hold them for the fullness of time.
Learn about John and the team behind A Patient Prospector.